In SVA here. Incredibly cheap China drug stock. Sales growing 141% and they added capacity in October- this and seasonality should give BLOWOUT Q4. Earned $.05 last quarter but with new capacity they should have $.30 EPS annual run rate- most drug stocks trade at minimum 35 PE.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.